Delay vital Hep C treatment review

In yet another spectacular own goal, NHS England has asked NICE to delay the evaluation of a lifesaving medication to treat Hep C, by a further 6 months. The drug in question Sofosbuvir was licenced for use late last year and a special access program has been in place...